S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(0.04%) $80.09

Gas
(1.75%) $2.67

Gold
(0.91%) $2 439.30

Silver
(3.81%) $32.45

Platinum
(0.81%) $1 098.80

USD/EUR
(-0.08%) $0.919

USD/NOK
(-0.15%) $10.66

USD/GBP
(-0.02%) $0.787

USD/RUB
(0.06%) $91.03

Realtime updates for Lincoln Pharmaceuticals [LINCOLN.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-23)

Expected move: +/- 6.53%

Last Updated18 May 2024 @ 02:59

25% discount on Stockinvest.us - Use code: Podcast

0.59% INR 576.15

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 02:59):

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics...

Stats
Today's Volume	13 775.00
Average Volume	101 039
Market Cap	11.54B
EPS	INR0 ( 2024-05-16 )
Next earnings date	( INR0 ) 2024-05-23
Last Dividend	INR1.500 ( 2023-09-15 )
Next Dividend	INR0 ( N/A )
P/E	13.23
ATR14	INR0.955 (0.17%)

Volume Correlation

Long: -0.16 (neutral)

Short: -0.37 (neutral)

Signal:(51.669) Neutral

Lincoln Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lincoln Pharmaceuticals Correlation - Currency/Commodity

-0.26
( neutral )

-0.14
( neutral )

-0.36
( neutral )

-0.18
( neutral )

-0.49
( neutral )

0.25
( neutral )

Lincoln Pharmaceuticals Financials

Annual	2023
Revenue:	INR5.81B
Gross Profit:	INR1.89B (32.50 %)
EPS:	INR46.58

FY	2023
Revenue:	INR5.81B
Gross Profit:	INR1.89B (32.50 %)
EPS:	INR46.58

FY	2022
Revenue:	INR5.10B
Gross Profit:	INR2.69B (52.70 %)
EPS:	INR36.40

FY	2022
Revenue:	INR4.68B
Gross Profit:	INR2.48B (53.06 %)
EPS:	INR34.63

Financial Reports:

No articles found.

Lincoln Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Lincoln Pharmaceuticals Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.31%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2016-09-23
Last Dividend	INR1.500	2023-09-15
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	INR11.20	--
Avg. Dividend % Per Year	0.32%	--
Score	3.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.17
Div. Directional Score	8.69	--

Next Divdend (Est)
(2024-06-25)

INR1.526 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.32

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR1.500	0.67%
2019	INR1.500	0.66%
2020	INR1.500	0.73%
2021	INR1.500	0.62%
2022	INR1.500	0.41%
2023	INR1.500	0.42%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
TORNTPHARM.NS	Dividend Junior	2023-06-23	Annually	22	0.85%
PERSISTENT.NS	Dividend Knight	2023-07-11	Semi-Annually	15	0.67%
IVP.NS	Dividend Junior	2023-08-03	Annually	23	0.72%
CUMMINSIND.NS	Dividend Knight	2023-07-25	Semi-Annually	23	1.39%
SIRCA.NS	Dividend Junior	2023-08-18	Annually	6	0.24%
MAZDA.NS	Dividend Junior	2023-09-07	Annually	8	1.43%
GROBTEA.NS	No Dividend Player	2023-08-02	Annually	9	0.17%
BALAMINES.NS	Dividend Knight	2023-07-03	Annually	18	0.27%
PREMEXPLN.NS	Dividend Junior	2023-09-22	Sporadic	8	0.23%
KABRAEXTRU.NS	Dividend Knight	2023-07-13	Annually	23	0.83%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.161	1.500	6.79	10.00	[0 - 0.5]
returnOnAssetsTTM	0.133	1.200	5.56	6.67	[0 - 0.3]
returnOnEquityTTM	0.171	1.500	9.22	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.84	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.82	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.150	1.500	-0.278	-0.418	[0.2 - 2]
debtRatioTTM	0.00152	-1.500	9.97	-10.00	[0 - 0.6]
interestCoverageTTM	66.88	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	10.34	2.00	6.55	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.34	2.00	4.83	9.66	[0 - 20]
debtEquityRatioTTM	0.00180	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.422	1.000	6.29	6.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.169	1.000	8.62	8.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	19.41	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.829	0.800	7.81	6.25	[0.5 - 2]
Total Score				12.21

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	12.37	1.000	8.85	0	[1 - 100]
returnOnEquityTTM	0.171	2.50	9.50	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.34	2.00	6.55	9.66	[0 - 30]
dividendYielPercentageTTM	0.260	1.500	3.49	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.34	2.00	6.55	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.082	1.500	6.12	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0357	1.000	-1.608	0	[0.1 - 0.5]
Total Score				5.17

Lincoln Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.